title: Morphological Changes within the Rat Lateral Ventricle after the Administration of Proteasome Inhibitors.
abstract: The broad variety of substances that inhibit the action of the ubiquitin-proteasome system (UPS)-known as proteasome inhibitors-have been used extensively in previous studies, and they are currently frequently proposed as a novel form of cancer treatment and as a protective factor in intracerebral hemorrhage treatment. The experimental data on the safest route of proteasome inhibitor administration, their associated side effects, and the possible ways of minimizing these effects have recently become a very important topic. The aim of our present study was to determine the effects of administering of MG-132, lactacystin and epoxomicin, compounds belonging to three different classes of proteasome inhibitors, on the ependymal walls of the lateral ventricle. Observations were made 2 and 8 weeks after the intraventricular administration of the studied substances dissolved in dimethyl sulfoxide (DMSO) into the lateral ventricle of adult Wistar rats. Qualitative and quantitative analysis of brain sections stained with histochemical and inmmunofluorescence techniques showed that the administration of proteasome inhibitors caused a partial occlusion of the injected ventricle in all of the studied animals. The occlusion was due to ependymal cells damage and subsequent ependymal discontinuity, which caused direct contact between the striatum and the lateral nuclei of the septum, mononuclear cell infiltration and the formation of a glial scar between these structures (with the activation of astroglia, microglia and oligodendroglia). Morphologically, the ubiquitin-positive aggregates corresponded to aggresomes, indicating impaired activity of the UPS and the accumulation and aggregation of ubiquitinated proteins that coincided with the occurrence of glial scars. The most significant changes were observed in the wall covering the striatum in animals that were administered epoxomicin, and milder changes were observed in animals administered lactacystin and MG-132. Interestingly, DMSO administration also caused damage to some of the ependymal cells, but the aggresome-like structures were not formed. Our results indicate that all of the studied classes of proteasome inhibitors are detrimental to ependymal cells to some extent, and may cause severe changes in the ventricular system. The safety implications of their usage in therapeutic strategies to attenuate intracerebral hemorrhagic injury and in brain cancer treatment will require further studies.
authors.affiliation: Department of Anatomy and Neurobiology, Medical University of Gdańsk, Gdańsk, Poland.
authors.forename: Sławomir
authors.initials: S
authors.lastname: Wójcik
authors.affiliation: Department of Anatomy and Neurobiology, Medical University of Gdańsk, Gdańsk, Poland.
authors.forename: Jan Henryk
authors.initials: JH
authors.lastname: Spodnik
authors.affiliation: Department of Anatomy and Neurobiology, Medical University of Gdańsk, Gdańsk, Poland.
authors.forename: Jerzy
authors.initials: J
authors.lastname: Dziewiątkowski
authors.affiliation: Department of Anatomy and Neurobiology, Medical University of Gdańsk, Gdańsk, Poland.
authors.forename: Edyta
authors.initials: E
authors.lastname: Spodnik
authors.affiliation: Department of Anatomy and Neurobiology, Medical University of Gdańsk, Gdańsk, Poland.
authors.forename: Janusz
authors.initials: J
authors.lastname: Moryś
mesh_terms: D000818:Animals; D001284:Atrophy / Q000139:chemically induced; D004805:Ependyma / Q000187:drug effects / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D018315:Glioma, Subependymal / Q000139:chemically induced; D020547:Lateral Ventricles / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008297:Male; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D061988:Proteasome Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D051381:Rats; D017208:Rats, Wistar; D012397:Rosette Formation; D025801:Ubiquitin / Q000378:metabolism
chemical_list: D061988:Proteasome Inhibitors; D025801:Ubiquitin; D046988:Proteasome Endopeptidase Complex